BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8797814)

  • 21. Decreased virus population diversity in p53-null mice infected with weakly oncogenic Abelson virus.
    Marchlik E; Kalman R; Rosenberg N
    J Virol; 2005 Sep; 79(18):11618-26. PubMed ID: 16140739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reassessment of murine APOBEC1 as a retrovirus restriction factor in vivo.
    Barrett BS; Guo K; Harper MS; Li SX; Heilman KJ; Davidson NO; Santiago ML
    Virology; 2014 Nov; 468-470():601-608. PubMed ID: 25303118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic regulation of long-term nonprogression in E-55+ murine leukemia virus infection in mice.
    Panoutsakopoulou V; Hunter K; Sieck TG; Blankenhorn EP; Blank KJ
    J Virol; 1999 Nov; 73(11):9232-6. PubMed ID: 10516031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. F-MuLV acceleration of myelomonocytic tumorigenesis in SV40 large T antigen transgenic mice is accompanied by retroviral insertion at Fli1 and a novel locus, Fim4.
    Kone J; Arroyo J; Savinelli T; Lin S; Boyd K; Wu Y; Nimmakayalu M; Copeland NG; Jenkins NA; Qumsiyeh M; Hu P; Prescott A; Wu H; Yang L; Roe B; Perkins AS
    Leukemia; 2002 Sep; 16(9):1827-34. PubMed ID: 12200699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of retrovirus gene expression in teratocarcinoma stem cells is limited to the nucleus.
    Gautsch JW
    Somatic Cell Genet; 1982 Mar; 8(2):143-9. PubMed ID: 9732745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular analysis and characterization of two myeloid leukemia inducing murine retroviruses.
    Rassart E; Houde J; Denicourt C; Ru M; Barat C; Edouard E; Poliquin L; Bergeron D
    Curr Top Microbiol Immunol; 1996; 211():201-10. PubMed ID: 8585951
    [No Abstract]   [Full Text] [Related]  

  • 27. Mutant murine leukemia virus Gag proteins lacking proline at the N-terminus of the capsid domain block infectivity in virions containing wild-type Gag.
    Rulli SJ; Muriaux D; Nagashima K; Mirro J; Oshima M; Baumann JG; Rein A
    Virology; 2006 Apr; 347(2):364-71. PubMed ID: 16427108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of tacrolimus on infection of Friend murine leukemia virus to Fv-4 gene heterozygous mice.
    Zhang FM; Yang BF; Gu HX; Chen XB; Zhong ZH; Cheng Z
    Acta Pharmacol Sin; 2004 Feb; 25(2):208-12. PubMed ID: 14769211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variation in host resistance could limit the spread of more broadly virulent pathogens.
    Barclay VC
    Virulence; 2013 Jul; 4(5):347-9. PubMed ID: 23689611
    [No Abstract]   [Full Text] [Related]  

  • 30. Charlotte Friend Memorial Lecture: murine leukemia virus (MuLV) tumorigenesis.
    Hartley JW; Chattopadhyay SK; Morse HC; Fredrickson TN
    Leukemia; 1997 Apr; 11 Suppl 3():147-8. PubMed ID: 9209325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic map of the region surrounding the retrovirus restriction locus, Fv1, on mouse chromosome 4.
    Stoye JP; Kaushik N; Jeremiah S; Best S
    Mamm Genome; 1995 Jan; 6(1):31-6. PubMed ID: 7719023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Host genetic factors that control immune responses to retrovirus infections.
    Miyazawa M; Tsuji-Kawahara S; Kanari Y
    Vaccine; 2008 Jun; 26(24):2981-96. PubMed ID: 18255203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Viral pathogenesis and immunity within the thymus.
    Gaulton GN
    Immunol Res; 1998; 17(1-2):75-82. PubMed ID: 9479569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynein Regulators Are Important for Ecotropic Murine Leukemia Virus Infection.
    Valle-Tenney R; Opazo T; Cancino J; Goff SP; Arriagada G
    J Virol; 2016 Aug; 90(15):6896-6905. PubMed ID: 27194765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The glycosylated gag protein of MuLV is a determinant of neuroinvasiveness: analysis of second site revertants of a mutant MuLV lacking expression of this protein.
    Portis JL; Fujisawa R; Mcatee FJ
    Virology; 1996 Dec; 226(2):384-92. PubMed ID: 8955058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Residues in the murine leukemia virus capsid that differentially govern resistance to mouse Fv1 and human Ref1 restrictions.
    Lassaux A; Sitbon M; Battini JL
    J Virol; 2005 May; 79(10):6560-4. PubMed ID: 15858043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 10A1 MuLV induces a murine leukemia that expresses hematopoietic stem cell markers by a mechanism that includes fli-1 integration.
    Ott DE; Keller J; Rein A
    Virology; 1994 Dec; 205(2):563-8. PubMed ID: 7975258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biological characterization and molecular cloning of murine C-type retroviruses derived from the TSZ complex from mainland China.
    Bundy LM; Ru M; Zheng BF; Cheng L; Pattengale PK; Portis JL; Fan H
    Virology; 1995 Oct; 212(2):367-82. PubMed ID: 7571406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations at the capsid-nucleocapsid cleavage site of gag polyprotein of Moloney murine leukemia virus abolish virus infectivity.
    Housset V; Darlix JL
    C R Acad Sci III; 1996 Feb; 319(2):81-9. PubMed ID: 8680959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation and characterization of a stable full-length ecotropic murine leukemia virus molecular clone that produces novel phenotypes to Fv1 restriction.
    Bae EH; Park SH; Park SM; Park JW; Lim MS; Jung YT
    J Microbiol Biotechnol; 2008 Apr; 18(4):799-804. PubMed ID: 18467880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.